The administration of Alb-IFNβ in combination with our vaccinia virus encoding the HPV-16 E7 antigen (HPV vaccinia-based vaccine) enhanced antigen-specific CD8+ T cell immunity in a syngeneic TC-1 tumor model. Here, IFNB1 is linked to neoplasm.